Looking beyond the baseline: new frontiers in lung and immune safety

Category
Reading Time

5 minutes

In ImmuBYTES Session 3, “Looking Beyond Baseline Deviations for Lung and Immune Safety,” Prof. Victoria Hutter (CSO & Co-founder) highlighted how subtle changes in macrophage morphology can uncover early immune and lung effects. Moving beyond baseline data, this approach enables faster, more predictive decisions in preclinical safety.

Key highlights include:

 

1. Why macrophages are Important in lung & immune safety

The session began by revisiting the vital role of alveolar macrophages as frontline defenders in the lungs. Their responses to inhaled compounds offer early and sensitive readouts of immune activation and safety risks – often well before tissue damage is visible.

2. High-Content Imaging in action – morph_ONE

This segment introduced morph_ONE, a multiparametric high-content imaging analysis tool developed to track subtle morphological shifts in macrophages. By quantifying cell shape, structure, and complexity, morph_ONE helps detect functional deviations from baseline that traditional methods may miss.

3. Rat vs. Human: baseline characteristics of macrophages

A critical step in translational science is understanding species-specific differences. This session compared rat and human macrophage baselines, revealing how divergence in cell morphology and behavior impacts predictivity—and why it’s essential to define “normal” with context.

4. Beyond the Baseline – categorising morphology changes

This is where the session delivered its core message. Prof. Hutter demonstrated how morphology-based categorization of macrophage changes offers a deeper, mechanistic understanding of immune responses. By going beyond the presence of change and asking what kind, we gain insight into the nature of immune activation—whether it’s adaptive, adverse, or neutral.

Below is a snippet of the session:

Watch the full ImmuBYTES session

Submit the form below and we’ll send you the full recording of the session:

Looking ahead

Morphological deviations are early immune risk signals. Using HCIA fingerprint profiling, we can quickly assess if candidates are safe or unsafe, enabling faster, more precise drug development decisions.

Want to advance your research? Contact our expert team to explore how we can support your inhalation toxicity studies.

See you at our next ImmuBYTES session in September.

Add a Comment

Related Posts

Using an animal-free assay

We’ve just returned from the Society of Toxicology conference in Nashville, where we were excited to exhibit our upcoming in vitro cell culture models.

Scroll to Top